---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-340664"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2026-08-07T22:49:53+00:00"
generated_at: "2026-08-10T10:05:27.104454+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notice on Aug 4, 2026: RKDA failed minimum bid price ($1.00) for 30 consecutive business days (Jun 22–Aug 3).
- 180-day cure period until Feb 1, 2027; must close at $1.00+ for 10 consecutive business days to regain compliance.
- Company may consider reverse stock split to cure deficiency; no immediate impact on listing or trading.
- If not cured by Feb 1, 2027, may qualify for additional 180-day period if other listing standards are met.

## SEC filing metadata
- accession: 0001193125-26-340664
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2026-08-07T22:49:53+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000119312526340664/0001193125-26-340664-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000119312526340664/rkda-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-340664
- JSON: https://secwatch.observer/filing/0001193125-26-340664.json
- Plain text: https://secwatch.observer/filing/0001193125-26-340664.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.